Search Results - "Lasagna, Angioletta"

In reply to: “A COVID-19 screening tool for oncology telephone triage” by Lasagna, Angioletta, Monaco, Teresa, Imarisio, Ilaria, Brugnatelli, Silvia

Get full text

Vaccine hesitancy in patients with solid tumors: a cross-sectional single-center survey by Lasagna, Angioletta, Alessio, Niccolò, Gambini, Giulia, Klersy, Catherine, Monaco, Teresa, Corallo, Salvatore, Cicognini, Daniela, Pedrazzoli, Paolo

“…Vaccination rates are still suboptimal in cancer patients. Oncologists play a central role in recommending vaccines to their patients. Our goal was to…”
Get full text

Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? by Lucioni, Marco, Rossi, Chiara, Lomoro, Pascal, Ballati, Francesco, Fanizza, Marianna, Ferrari, Alberta, Garcia-Etienne, Carlos A., Boveri, Emanuela, Meloni, Giulia, Sommaruga, Maria Grazia, Ferraris, Elisa, Lasagna, Angioletta, Bonzano, Elisabetta, Paulli, Marco, Sgarella, Adele, Di Giulio, Giuseppe

“…Purpose Breast lesions classified as of “uncertain malignant potential” represent a heterogeneous group of abnormalities with an increased risk of associated…”
Get full text

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up by Lasagna, Angioletta, Cassaniti, Irene, Arena, Francesca, Bergami, Federica, Percivalle, Elena, Comolli, Giuditta, Sarasini, Antonella, Ferrari, Alessandro, Cicognini, Daniela, Schiavo, Roberta, Lo Cascio, Giuliana, Pedrazzoli, Paolo, Baldanti, Fausto

“…The role and durability of the immunogenicity of the BNT162b2 mRNA vaccine against severe acute respiratory virus 2 (SARS-CoV-2), in cancer patients one year…”
Get full text

Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study by Lasagna, Angioletta, Albi, Giuseppe, Maserati, Renato, Zuccarini, Andrea, Quaccini, Mattia, Baldanti, Fausto, Sacchi, Paolo, Bruno, Raffaele, Pedrazzoli, Paolo

“…Few data about the safety of immune checkpoint inhibitors (ICIs) in the patients with solid tumor with Occult Hepatitis B Virus (OBI) are available. According…”
Get full text

The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy by Lasagna, Angioletta, Mele, Dalila, Bergami, Federica, Alaimo, Domiziana, Dauccia, Chiara, Alessio, Nicolò, Comolli, Giuditta, Pasi, Francesca, Muzzi, Alba, Novelli, Viola, Baldanti, Fausto, Pedrazzoli, Paolo, Cassaniti, Irene

“…Herpes zoster (HZ) is caused by the reactivation of latent varicella zoster virus (VZV). Severe immunocompromising conditions, such as solid tumors, have been…”
Get full text

Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy by Lasagna, Angioletta, Mascaro, Federica, Figini, Simone, Basile, Sara, Gambini, Giulia, Klersy, Catherine, Lenti, Marco Vincenzo, Di Sabatino, Antonio, Di Benedetto, Alice, Calvi, Monica, Bruno, Raffaele, Sacchi, Paolo, Pedrazzoli, Paolo

“…Introduction The gut microbiota (GM) can influence the pathogenesis of immune‐mediated adverse events (irAEs). Proton pump inhibitors (PPIs) can affect the…”
Get full text

Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review by Corallo, Salvatore, Lasagna, Angioletta, Filippi, Beatrice, Alaimo, Domiziana, Tortorella, Anna, Serra, Francesco, Vanoli, Alessandro, Pedrazzoli, Paolo

“…Gastric cancer (GC) is a complex disease with various etiologies. While infection is still one of the leading risk factors for GC, increasing evidence suggests…”
Get full text

The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature by Rossi, Chiara, Inzani, Frediano Socrate, Cesari, Stefania, Rizzo, Gianpiero, Paulli, Marco, Pedrazzoli, Paolo, Lasagna, Angioletta, Lucioni, Marco

“…Breast cancer is the most common malignancy in the female sex; although recent therapies have significantly changed the natural history of this cancer, it…”
Get full text

Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study by Asperges, Erika, Albi, Giuseppe, Zuccaro, Valentina, Sambo, Margherita, Pieri, Teresa C., Calia, Matteo, Colaneri, Marta, Maiocchi, Laura, Melazzini, Federica, Lasagna, Angioletta, Peri, Andrea, Mojoli, Francesco, Sacchi, Paolo, Bruno, Raffaele

“…Introduction The hyperinflammation phase of severe SARS-CoV-2 is characterised by complete blood count alterations. In this context, the…”
Get full text

Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment by Lasagna, Angioletta, Cassaniti, Irene, Lilleri, Daniele, Quaccini, Mattia, Ferrari, Alessandra, Sacchi, Paolo, Bruno, Raffaele, Baldanti, Fausto, Pedrazzoli, Paolo

“…Emergency use authorization of drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by regulatory authorities has provided new options to…”
Get full text

Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir by Lasagna, Angioletta, Piralla, Antonio, Secondino, Simona, Sacchi, Paolo, Baldanti, Fausto, Bruno, Raffaele, Pedrazzoli, Paolo

“…Coronavirus disease (COVID-19) in patients undergoing hematopoietic stem cell transplantation (HSCT) is a major issue. None of the published papers have…”
Get full text

The Role of Pre-treatment Inflammatory Biomarkers in the Prediction of an Early Response to Panitumumab in Metastatic Colorectal Cancer by Lasagna, Angioletta, Muzzana, Marta, Ferretti, Virginia V, Klersy, Catherine, Pagani, Anna, Cicognini, Daniela, Pedrazzoli, Paolo, Brugnatelli, Silvia G

“…Background Systemic inflammation is a critical component of the development and progression of several types of cancer. Neutrophil-lymphocyte ratio (NLR) and…”
Get full text

Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma by Serra, Francesco, Faverio, Carlotta, Lasagna, Angioletta, Barruscotti, Stefania, Dominioni, Tommaso, Benazzo, Marco, Pedrazzoli, Paolo, Chiellino, Silvia

“…The clinical management of BRAF -mutated metastatic melanoma had an important turning point after the introduction of the targeted therapy. Despite the…”
Get full text

The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study by Lasagna, Angioletta, De Amici, Mara, Rossi, Chiara, Zuccaro, Valentina, Corbella, Marta, Petazzoni, Greta, Comandatore, Francesco, Sacchi, Lucia, Testa, Giorgia, Ferraris, Elisa, Rizzo, Gianpiero, Tancredi, Richard, Ferrari, Alessandra, Lucioni, Marco, Sacchi, Paolo, Bruno, Raffaele, Pedrazzoli, Paolo

“…The interactions between aromatase inhibitors (AI) in breast cancer (BC) and gut microbiota (GM) have not been completely established yet. The aim of the study…”
Get full text

Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems by Jacobs, Flavia, D’Amico, Saverio, Zazzetti, Elena, Gaudio, Mariangela, Benvenuti, Chiara, Saltalamacchia, Giuseppe, Gerosa, Riccardo, Gentile, Damiano, Lasagna, Angioletta, Pedrazzoli, Paolo, Tinterri, Corrado, Santoro, Armando, Sanctis, Rita De, Porta, Matteo Della, Zambelli, Alberto

“…Modern healthcare is experiencing a significant transformation, utilizing technology to improve patient outcomes and make processes more efficient. Breast…”
Get full text

The ABC of Immune-Mediated Hepatitis during Immunotherapy in Patients with Cancer: From Pathogenesis to Multidisciplinary Management by Lasagna, Angioletta, Sacchi, Paolo

“…Immune-mediated hepatotoxicity (IMH) is not-so-rare complication during treatment with immune checkpoint inhibitors (ICIs). This narrative review aims to…”
Get full text

Lingual Metastasis from Renal Cell Carcinoma: A Case Report and Literature Review by Ganini, Carlo, Lasagna, Angioletta, Ferraris, Elisa, Gatti, Patrizia, Paglino, Chiara, Imarisio, Ilaria, Morbini, Patrizia, Benazzo, Marco, Porta, Camillo

“…Renal cell carcinoma (RCC) accounts for the 3% of all solid tumors. Despite continuous improvement in the therapy regimen, less has been achieved in terms of…”
Get full text

G-CSF and G-CSF-related vasculitis: a systematic review of the literature and intriguing future research perspectives by Muzzana, Marta, Pedrazzoli, Paolo, Lasagna, Angioletta

“…There are several case reports suggesting that G-CSFs may, in rare conditions, produce serious side effects, such as vasculitis. A systematic search was…”
Get full text

A case report of pulmonary nocardiosis during pembrolizumab: the emerging challenge of the infections on immunotherapy by Lasagna, Angioletta, Arlunno, Bryan, Imarisio, Ilaria

“…The increasing occurrence of infectious complications during immune checkpoint inhibitor (ICI) therapy is an emerging challenge for oncologists. ICIs can…”
Get full text